Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Clinical trial NCT06243185 · UNKNOWN

Trial details

NCT number: NCT06243185
Sponsor: Fengzhi Feng
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Carcinoma

Start date: 2023-11-17
Primary completion: 2024-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.